Kowsar Pharmaceutical Company (DKOSAR) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DKOSAR
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/09/30 | To 1403/09/30 | To 1402/09/30 | To 1401/09/30 | To 1400/09/30 |
|---|---|---|---|---|---|---|
| Operating revenue | 13,152,018 | 7,836,119 | 12,195,916 | 9,726,058 | 5,239,515 | 1,826,916 |
| Cost of operating revenue | -8,625,822 | -8,784,642 | -9,019,333 | -6,363,119 | -3,013,115 | -1,369,156 |
| Gross profit (loss) | 4,526,196 | -948,523 | 3,176,583 | 3,362,939 | 2,226,400 | 457,760 |
| Selling, general and administrative expenses | -910,971 | -750,204 | -621,178 | -480,097 | -314,289 | -231,016 |
| Other income | 13,521 | 6,523 | 203 | 0 | 0 | 365 |
| Other expenses | -8,825 | -114,580 | -13,863 | -59,517 | -25,856 | -16,010 |
| Operating profit (loss) | 3,619,921 | -1,806,784 | 2,541,745 | 2,823,325 | 1,886,255 | 211,099 |
| Finance costs | -1,528,802 | -1,764,886 | -1,967,917 | -696,242 | -497,287 | -366,893 |
| Other non-operating income and expenses | 4,684,199 | 4,615,497 | 77,167 | 21,920 | 17,347 | 11,293 |
| Profit (loss) from continuing operations before tax | 6,775,318 | 1,043,827 | 650,995 | 2,149,003 | 1,406,315 | -144,501 |
| Current year tax | -570,194 | 0 | -130,199 | -429,800 | -270,100 | 0 |
| Net profit (loss) from continuing operations | 6,205,124 | 1,043,827 | 520,796 | 1,701,412 | 1,117,111 | -144,501 |
| Net profit (loss) | 6,205,124 | 1,043,827 | 520,796 | 1,701,412 | 1,117,111 | -144,501 |
| Basic earnings (loss) per share | 1,794 rials | 307 rials | 306 rials | 1,001 rials | 657 rials | -85 rials |
| Net earnings (loss) per share, rials | 1,826 rials | 308 rials | 307 rials | 1,001 rials | 658 rials | -85 rials |
| Capital | 3,400,000 | 3,400,000 | 1,700,000 | 1,700,000 | 1,700,000 | 1,700,000 |
Reporting periods
88 periods are on file for this report, from the period ending 1381/12/29 to the period ending 1405/06/31.